• Zinc, Serum
  • Actinomyces, Molecular Method
  • CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • Rubella Antibody, IgG
  • Apolipoprotein Assessment
  • Respiratory Pathogen (Pneumonia) Panel with Antibiotic Resistance Genes, Molecular
  • Protein Creatinine Ratio, Random, Urine
  • Alveolar Soft Part Sarcoma (ASPS)/Renal Cell Carcinoma (RCC), Xp11.23 (TFE3), FISH, Tissue
  • Beta-2 Glycoprotein 1 Antibody, IgG
  • Mercury, 24 Hour, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
Medical Test

CPT
Access to Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS is restricted.
Loading...